Celldex Therapeutics
CLDX
#4577
Rank
NZ$2.97 B
Marketcap
$44.89
Share price
-0.68%
Change (1 day)
-2.98%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.93

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.11. In 2022 the company made an earnings per share (EPS) of -$4.09 a decrease over its 2021 EPS that were of -$2.81.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.93-3.83%
2022-$4.0945.73%
2021-$2.81-23.36%
2020-$3.66-41.05%
2019-$6.21-76.95%
2018-$26.9645.03%
2017-$18.59-42.54%
2016-$32.35-3.82%
2015-$33.64-0.76%
2014-$33.9029.41%
2013-$26.190%
2012-$26.19-9.73%
2011-$29.021312.5%
2010-$2.05-95.79%
2009-$48.75-49.64%
2008-$96.81-82.64%
2007-$557.74-44.98%
2006-$1,0141270.83%
2005-$73.9533.33%
2004-$55.47-10%
2003-$61.63-16.67%
2002-$73.95-38.46%
2001-$120.18-4.88%
2000-$126.34-81.66%
1999-$688.69-87.2%
1998-$5,378206.39%
1997-$1,75513.02%
1996-$1,553

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.86 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.46-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$20.68 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.22-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.18-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.99-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.98-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA